The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...
Lifestyle and socio-economic factors are often linked to the higher prevalence of obesity, type 2 diabetes, and cardiovascular disease among native Hawaiians. However,...